Written Question·Department of Health and Social Care·UIN 73912

Tirzepatide

Tabled: 1 September 2025

Answered: 9 September 2025

Named Day

Question

Laurence Turner

To ask the Secretary of State for Health and Social Care, with reference to NHS England’s publication entitled Interim commissioning guidance: Implementation of the NICE Technology Appraisal TA1026 and the NICE funding variation for tirzepatide (Mounjaro)

Answer

Ashley Dalton

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing evidence-based guidance for the National Health Service on the use of licensed medicines based on an assessment of their clinical and cost-effe...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 73912) →